Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 20,800 | -11,400 | -28,500 | -43,000 | 12,700 |
| Depreciation Amortization | 9,700 | 57,400 | 44,400 | 33,300 | 16,300 |
| Income taxes - deferred | N/A | -29,700 | -9,300 | -9,500 | N/A |
| Accounts receivable | -12,400 | -4,700 | -7,800 | -100 | -6,700 |
| Other Working Capital | -30,800 | -2,800 | -33,600 | -38,000 | -30,200 |
| Other Operating Activity | 11,800 | 92,400 | 91,900 | 85,000 | 2,300 |
| Operating Cash Flow | $-900 | $101,200 | $57,100 | $27,700 | $-5,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5,300 | -27,800 | -20,800 | -13,900 | -7,000 |
| Net Acquisitions | N/A | 45,000 | 45,000 | 45,000 | N/A |
| Purchase Of Investment | -500 | -10,600 | -9,000 | -6,700 | -4,000 |
| Purchase Sale Intangibles | -1,700 | -8,000 | -2,600 | -1,700 | -600 |
| Other Investing Activity | -1,700 | -10,500 | -2,600 | -1,700 | -600 |
| Investing Cash Flow | $-7,500 | $-3,900 | $12,600 | $22,700 | $-11,600 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -600 | 31,300 | 26,700 | 25,700 | 8,100 |
| Debt Issued | 20,000 | 180,000 | 145,100 | 127,300 | 59,000 |
| Debt Repayment | -31,100 | -211,200 | -166,700 | -135,400 | -56,000 |
| Common Stock Issued | 3,300 | 8,900 | 6,500 | 3,600 | 1,600 |
| Common Stock Repurchased | -1,800 | -700 | N/A | N/A | N/A |
| Other Financing Activity | -300 | -86,900 | -87,000 | -38,000 | -6,300 |
| Financing Cash Flow | $-10,500 | $-78,600 | $-75,400 | $-16,800 | $6,400 |
| Exchange Rate Effect | -800 | 900 | 1,100 | -100 | 600 |
| Beginning Cash Position | 47,700 | 28,100 | 28,100 | 28,100 | 28,100 |
| End Cash Position | 28,000 | 47,700 | 23,500 | 61,600 | 17,900 |
| Net Cash Flow | $-19,700 | $19,600 | $-4,600 | $33,500 | $-10,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | -900 | 101,200 | 57,100 | 27,700 | -5,600 |
| Capital Expenditure | -7,600 | -37,500 | -28,100 | -18,800 | -9,400 |
| Free Cash Flow | -8,500 | 63,700 | 29,000 | 8,900 | -15,000 |